Head and neck cancer stem cells

Journal of Dental Research

Volumn 91, Issue 4, 2012, Pages 334-340

  Krishnamurthy, S ^a   Nor J E ^a,b,c  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b University of Michigan   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

angiogenesis; head and neck squamous cell carcinoma; oral cancer; perivascular niche; therapy; tumorigenesis

Indexed keywords

TUMOR MARKER;

BLOOD VESSEL; CANCER INVASION; CANCER STEM CELL; HEAD AND NECK TUMOR; HUMAN; METASTASIS; PATHOLOGY; PHYSIOLOGY; REVIEW; SQUAMOUS CELL CARCINOMA; STEM CELL NICHE; TUMOR RECURRENCE;

BLOOD VESSELS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; STEM CELL NICHE; TUMOR MARKERS, BIOLOGICAL;

EID: 84859045046     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034511423393     Document Type: Review

References (60)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003 ; 100: 3983-3988 (Pubitemid 36418143)
2. Albers AE, Chen C, Köberle B, Qian X, Klussmann JP, Wollenberg B, et al. Stem cells in squamous head and neck cancer. Crit Rev Oncol/Hematol. 2011 ;:
3. Baumann M, Krause M. CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy. Clin Cancer Res. 2010 ; 16: 5091-5093
4. Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self-renewal, multi-potency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004 ; 118: 635-648 (Pubitemid 39179715)
5. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997 ; 3: 730-737 (Pubitemid 27298715)
6. Borovski T, De Souza E, Melo F, Vermeulen L, Medema JP. Cancer stem cell niche: the place to be. Cancer Res. 2011 ; 71: 634-639
7. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 2006 ; 20: 1123-1136
8. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007 ; 11: 69-82 (Pubitemid 46054518)
9. Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun. 2009 ; 385: 307-313
10. Chikamatsu K, Ishii H, Takahashi G, Okamoto A, Moriyama M, Sakakura K, et al. Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells. Head Neck. 2011 :
11. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high grade oral squamous cell carcinoma. Clin Cancer Res. 2008 ; 14: 4085-4095
12. Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, Belloni B, et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res. 2011 ; 71: 3098-3119
13. Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck. 2010 ; 32: 1195-1201
14. Dontu G, Abdullah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003 ; 17: 1253-1270 (Pubitemid 36583168)
15. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990 ; 247: 49-56
16. Forastiere AA. Chemotherapy in the treatment of locally advanced head and neck cancer. J Surg Oncol. 2008 ; 97: 701-707 (Pubitemid 351812972)
17. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbours: stem cells and their niche. Cell. 2004 ; 116: 769-778 (Pubitemid 38410723)
18. Furth J, Kahn M. The transmission of leukemia of mice with a single cell. Am J Cancer. 1937 ; 31: 276-282
19. Gao L, Yan L, Lin B, Gao J, Liang X, Wang Y, et al. Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I. J Exp Clin Cancer Res. 2011 ; 30: 15
20. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007 ; 1: 555-567 (Pubitemid 350056407)
21. Girouard SD, Murphy GF. Melanoma stem cells: not rare, but well done. Lab Invest. 2011 ; 91: 647-664
22. Hamburger A, Salmon SE. Primary bioassay of human myeloma stem cells. J Clin Invest. 1977 ; 60: 846-854 (Pubitemid 8208477)
23. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000 ; 100: 57-70 (Pubitemid 30046295)
24. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 ; 144: 646-674
25. Harper LJ, Piper K, Common J, Fortune F, Mackenzie IC. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J Oral Pathol Med. 2007 ; 36: 594-603 (Pubitemid 47609813)
26. Hayry V, Makinen LK, Atula T, Sariola H, Makitie A, Leivo I, et al. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer. 2010 ; 102: 892-897
27. Hewitt HB. Studies of the dissemination and quantitative transplantation of a lymphocytic leukaemia of CBA mice. Br J Cancer. 1958 ; 12: 378-401
28. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer Statistics 2007. CA Cancer J Clin. 2007 ; 57: 43-66
29. Jensen JB, Parmar M. Strengths and limitations of the neurosphere culture system. Mol Neurobiol. 2006 ; 34: 153-161
30. Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci USA. 2011 ; 108: 3749-3754
31. Krishnamurthy S, Dong Z, Vodopyanov D, Imai A, Helman JI, Prince ME, et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res. 2010 ; 70: 9969-9978
32. Kuhn NZ, Tuan RS. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol. 2010 ; 222: 268-277
33. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature. 1994 ; 367: 645-648 (Pubitemid 24067706)
34. Larson GT, Adams GL, Fattah HA. Survival statistics for multiple primaries in head and neck cancer. Otolaryngol Head Neck Surg. 1990 ; 103: 14-24 (Pubitemid 20226126)
35. Lo WL, Yu CC, Chiou GY, Chen YW, Huang PI, Chien CS, et al. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck carcinoma stem cells. J Pathol. 2011 ; 223: 482-495
36. Locke M, Heywood M, Fawell S, Mackenzie IC. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res. 2005 ; 65: 8944-8950 (Pubitemid 41377385)
37. Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, et al. Anti-angiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009 ; 15: 220-231
38. Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, et al. Targeting Notch to target cancer stem cells. Clin Cancer Res. 2010 ; 16: 3141-3152
39. Pastrana E, Silva-Vargas V, Doetsch F. Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell. 2011 ; 8: 486-498
40. Pierce GB, Wallace C. Differentiation of malignant to benign cells. Cancer Res. 1971 ; 31: 127-134
41. Prince ME, Ailles LE. Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol. 2008 ; 26: 2871-2875
42. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 2007 ; 104: 973-978 (Pubitemid 46154721)
43. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumor formation by single human melanoma cells. Nature. 2008 ; 456: 593-598
44. Rasper M, Schäfer A, Piontek G, Teufel J, Brockhoff G, Ringel F, et al. Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro Oncol. 2010 ; 12: 1024-1033
45. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001 ; 414: 105-111 (Pubitemid 33041634)
46. Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev. 2007 ; 26: 645-662 (Pubitemid 350115112)
47. Shiozawa Y, Pienta KJ, Taichman RS. Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors. Clin Cancer Res. 2011 ;:
48. Shmelkov SV, St.Clair R, Lyden D, Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol. 2005 ; 37: 715-719 (Pubitemid 40202993)
49. Sobreira TJ, Marlétaz F, Simões-Costa M, Schechtman D, Pereira AC, Brunet F, et al. Structural shifts of aldehyde dehydrogenase enzymes were instrumental for the early evolution of retinoid-dependent axial patterning in metazoans. Proc Natl Acad Sci USA. 2011 ; 108: 226-231
50. Taghizadeh R, Noh M, Huh YH, Ciusani E, Sigalotti L, Maio M, et al. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells. PLoS One. 2010 ; 5: 15183
51. Takahashi-Yanaga F, Kahn M. Targeting Wnt signaling: can we safely eradicate cancer stem cells?. Clin Cancer Res. 2010 ; 16: 3153-3162
52. Takezaki T, Hide T, Takanaga H, Nakamura H, Kuratsu J, Kondo T. Essential role of the Hedgehog signaling pathway in human glioma-initiating cells. Cancer Sci. 2011 ; 102: 1306-1312
53. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007 ; 357: 1695-1704 (Pubitemid 350005151)
54. Vries RG, Huch M, Clevers H. Stem cells and cancer of the stomach and intestine. Mol Oncol. 2010 ; 4: 373-384
55. Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope. 2009 ; 119: 1518-1530
56. Wu Y, Wu PY. CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev. 2009 ; 18: 1127-1134
57. Yu CC, Chen YW, Chiou GY, Tsai LL, Huang PI, Chang CY, et al. MicroRNAlet-7a represses chemoresistance and tumorigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol. 2011 ; 47: 202-210
58. Zhang P, Zhang Y, Mao L, Zhang Z, Chen W. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett. 2009 ; 277: 227-234
59. Zhang Q, Shi S, Yen Y, Brown J, Ta JQ, Le AD. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett. 2010 ; 289: 151-160
60. Zhou L, Wei X, Cheng L, Tian J, Jiang JJ. CD133, one of the markers of cancer stem cells in Hep-2 cell line. Laryngoscope. 2007 ; 117: 455-460 (Pubitemid 46407753)